Large Volume Parenteral Market Poised to Grow at 3.1% CAGR Through 2031 | B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc., BML Parenteral Drugs

Large Volume Parenteral (LVP) Market is estimated to growth at a CAGR of 3.1% over the forecast period 2024-2031.

The Large Volume Parenteral Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/large-volume-parenteral-market?sg

Latest developments 2025:

✅ FDA declares U.S. saline shortage resolved (NaCl 0.9% IV solutions) - FDA removed sodium chloride 0.9% injection from its current shortages list (Aug 8, 2025).

✅ AHA echoes FDA update & Baxter allocation recovery - AHA notes FDA's shortage resolution and that Baxter had earlier raised allocations of two NaCl IV solutions to 100% (Aug 11, 2025; references Jan 22, 2025 Baxter customer notice).

✅ Mergers, acquisitions & strategic partnerships (2025)

ICU Medical × Otsuka Pharmaceutical Factory - JV completed - Creates one of the world's largest IV-solutions manufacturing networks (~1.4 billion units/year capacity), aimed at innovation and North American supply resilience (May 1, 2025).

✅ Product launches & portfolio moves (2025)

➠ B. Braun - Launched additional premixed Heparin Sodium bags, expanding to seven premix SKUs in the U.S. (Jul 18-21, 2025). These are DEHP-free IV bags with enhanced barcoding. (250 mL+ formats fall under LVP scope.)

➠ Endo (Par Sterile/Par Pharmaceutical) - Began shipping ADRENALIN® (epinephrine) 8 mg/250 mL premixed bag in 0.9% sodium chloride-a ready-to-use large-volume presentation (week of May 19, 2025).

Large Volume Parenteral (LVP) Market Key Drivers:

➠ Rising Prevalence of Chronic and Infectious Diseases

Growing cases of diabetes, cancer, gastrointestinal disorders, and infectious diseases increase the demand for intravenous therapies and nutritional support, fueling LVP adoption.

➠ Increasing Hospital Admissions and Surgical Procedures

Higher rates of elective and emergency surgeries worldwide are boosting the consumption of saline, dextrose, and Ringer's lactate solutions for fluid replacement and post-operative care.

➠ Growing Geriatric Population

Elderly patients often require parenteral nutrition and hydration support due to reduced oral intake and complex disease profiles, significantly driving LVP demand.

➠ Advancements in Manufacturing and Packaging

Innovations in sterile processing, aseptic filling, and flexible packaging solutions (such as non-PVC bags) enhance product safety, shelf life, and ease of handling, contributing to higher adoption.

➠ Expanding Access to Healthcare in Emerging Economies

Government initiatives, public-private investments, and healthcare reforms are expanding hospital networks, thereby increasing the use of parenteral products in underserved regions.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/large-volume-parenteral-market?sg

Market Geographical Share:

The Large Volume Parenteral (LVP) market demonstrates strong global demand, with regional contributions varying due to healthcare infrastructure, prevalence of chronic diseases, and pharmaceutical manufacturing capabilities:

North America: Holds a significant share driven by the rising demand for intravenous solutions in hospitals, robust healthcare spending, and the growing prevalence of lifestyle-related disorders such as diabetes and cardiovascular diseases. The presence of advanced distribution channels further strengthens regional dominance.

Europe: Contributes substantially, with demand propelled by an aging population, expanding use of parenteral nutrition, and increasing adoption of injectable therapies for oncology and critical care. Regulatory emphasis on quality and safety also supports stable growth.

Asia-Pacific: Expected to witness the fastest expansion due to rapid improvements in healthcare infrastructure, government initiatives to strengthen hospital capacities, and cost-effective drug manufacturing hubs in countries like India and China. The region's large patient base and increasing surgical procedures create strong growth opportunities.

Latin America & Middle East/Africa: Represent emerging markets, supported by improving access to healthcare, expanding pharmaceutical production, and rising investments in hospital infrastructure. These regions are increasingly targeted for capacity expansion by global manufacturers.

Strategic Players Driving the Large Volume Parenteral Market: B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc., BML Parenteral Drugs, Emcure Pharmaceuticals Ltd, Otsuka Pharmaceutical Factory, Inc., Beximco Pharma, China Resources Pharmaceutical GroupCo., Ltd. and Ozon Pharmaceuticals.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Research Methodology:

The global Large Volume Parenteral Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Large Volume Parenteral Market:

By Volume(250 ml - 500 ml, 100 ml - 250 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml)

By Application( Nutritious Injections, Vitamin B12, Isolyte M in Dextrose, Fluid Balance Injections, Hypertonic Saline (3% and 5% Sodium Chloride Injection, 5% Dextrose and Electrolyte, Therapeutic Injection)

By Type of Packaging(Bottles, Bags)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Large Volume Parenteral Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Large Volume Parenteral Market Research Industry:

➠ Who leads the Large Volume Parenteral industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Large Volume Parenteral market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Large Volume Parenteral market growth?

➠ What are the dominant sales and distribution strategies in the Large Volume Parenteral industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.